tiprankstipranks
Conduit Pharmaceuticals (CDT)
NASDAQ:CDT
US Market

Conduit Pharmaceuticals (CDT) Stock News & Sentiment

42 Followers
Conduit Pharmaceuticals Receives Patent Approval For Its Lead Asset Targeting Autoimmune Diseases
PremiumPress Releases
Conduit Pharmaceuticals Receives Patent Approval For Its Lead Asset Targeting Autoimmune Diseases
2d ago
Conduit Pharmaceuticals Appoints Dr. Joanne Holland as Chief Scientific Officer
PremiumPress Releases
Conduit Pharmaceuticals Appoints Dr. Joanne Holland as Chief Scientific Officer
4M ago
Conduit Pharmaceuticals Announces Opening of Prime Laboratory Space in Europe’s Leading Life Sciences Hub
PremiumPress Releases
Conduit Pharmaceuticals Announces Opening of Prime Laboratory Space in Europe’s Leading Life Sciences Hub
4M ago

News Score - Last 7 Days

Neutral
CDT
Sector Average
Media Buzz
This Week6 articles
Weekly Average1.5 articles
News Sentiment
This Week50%
Sector Average61%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is CDT’s Media Buzz Sentiment?
6 articles about CDT were published this week. In an average week, 1.5 articles are published.
    What is CDT’s weekly average amount of articles?
    In an average week, 1.5 articles about CDT are published.
      What is CDT’s News Sentiment?
      50% of articles about CDT were positive this week, compared to its sector average of 61%.
        Healthcare Stocks that are Trending in the News
        GMEDGlobus Medical
        UNHUnitedHealth
        HAEHaemonetics
        JNJJohnson & Johnson
        ELVElevance Health
        Showing the stocks with the most bullish news sentiment over the past week
        What's Included in PREMIUM?
        Make informed decisions based on Top Analysts' activity
        Know what industry insiders are buying
        Get actionable alerts from top Wall Street Analysts
        Find out before anyone else which stock is going to shoot up
        Get powerful stock screeners & detailed portfolio analysis